Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer
Clinical trial NCT03430479 · COMPLETED
Trial details
- NCT number
- NCT03430479
- Sponsor
- Kyoto Breast Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2018-11-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.